OCULAR ABSORPTION FOLLOWING TOPICAL DELIVERY

被引:269
作者
JARVINEN, K
JARVINEN, T
URTTI, A
机构
[1] KUOPIO UNIV,DEPT PHARMACEUT,KUOPIO,FINLAND
[2] KUOPIO UNIV,DEPT PHARMACEUT CHEM,KUOPIO,FINLAND
[3] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143
关键词
OPHTHALMIC DRUG; DRUG DELIVERY; OCULAR ABSORPTION; CYCLODEXTRIN; OCULAR PHARMACOKINETICS; CORNEAL PERMEABILITY;
D O I
10.1016/0169-409X(95)00010-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most ocular diseases are treated with topical application of eyedrops. After instillation of an eyedrop, typically less than 5% of the applied drug penetrates the cornea and reaches intraocular tissues, while a major fraction of the instilled dose is absorbed and enters the systemic circulation. Ocular absorption of topically applied ophthalmic drugs is limited by rapid precorneal drug elimination due to solution drainage and systemic absorption from the conjunctival sac. Another factor that limits ocular absorption is the corneal epithelial barrier. In the eye drugs are distributed from the aqueous humor to intraocular tissues and eliminated mainly via aqueous humor turnover and venous blood flow in the anterior uvea. Because of the publication of several reviews [1-3] on ocular drug absorption this review will focus on the most recent literature.
引用
收藏
页码:3 / 19
页数:17
相关论文
共 170 条
  • [1] AHMED I, 1985, INVEST OPHTH VIS SCI, V26, P584
  • [2] PHYSICOCHEMICAL DETERMINANTS OF DRUG DIFFUSION ACROSS THE CONJUNCTIVA, SCLERA, AND CORNEA
    AHMED, I
    GOKHALE, RD
    SHAH, MV
    PATTON, TF
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (08) : 583 - 586
  • [3] DISPOSITION OF TIMOLOL AND INULIN IN THE RABBIT EYE FOLLOWING CORNEAL VERSUS NON-CORNEAL ABSORPTION
    AHMED, I
    PATTON, TF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 38 (1-3) : 9 - 21
  • [4] COMPARATIVE DISSOLUTION CHARACTERISTICS OF BROPIRIMINE-BETA-CYCLODEXTRIN INCLUSION COMPLEX AND ITS SOLID DISPERSION WITH PEG-6000
    AHMED, SM
    ABDELRAHMAN, AA
    SALEH, SI
    AHMED, MO
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 96 (1-3) : 5 - 11
  • [5] EFFECT OF CYCLODEXTRIN DERIVATIVES ON INDOMETHACIN STABILITY IN AQUEOUS-SOLUTION
    BACKENSFELD, T
    MULLER, BW
    WIESE, M
    SEYDEL, JK
    [J]. PHARMACEUTICAL RESEARCH, 1990, 7 (05) : 484 - 490
  • [6] BARZA M, 1986, OPHTHALMOLOGY, V93, P133
  • [7] CYCLODEXTRINS IN THE PHARMACEUTICAL FIELD
    BEKERS, O
    UIJTENDAAL, EV
    BEIJNEN, JH
    BULT, A
    UNDERBERG, WJM
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (11) : 1503 - 1549
  • [8] ORAL PHARMACOKINETICS OF CARBAMAZEPINE IN DOGS FROM COMMERCIAL TABLETS AND A CYCLODEXTRIN COMPLEX
    BETLACH, CJ
    GONZALEZ, MA
    MCKIERNAN, BC
    NEFFDAVIS, C
    BODOR, N
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (10) : 1058 - 1060
  • [9] REGULATION OF TIGHT JUNCTION PERMEABILITY BY CALCIUM MEDIATORS AND CELL CYTOSKELETON IN RABBIT TRACHEAL EPITHELIUM
    BHAT, M
    TOLEDOVELASQUEZ, D
    WANG, L
    MALANGA, CJ
    MA, JKH
    ROJANASAKUL, Y
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (07) : 991 - 997
  • [10] SITE-SPECIFIC AND STEREOSPECIFIC OCULAR DRUG DELIVERY BY SEQUENTIAL ENZYMATIC BIOACTIVATION
    BODOR, N
    PROKAI, L
    [J]. PHARMACEUTICAL RESEARCH, 1990, 7 (07) : 723 - 725